{"DataElement":{"publicId":"4291780","version":"1","preferredName":"Accelerated Phase of Disease Finding Present Type","preferredDefinition":"A description of accelerated phase findings.","longName":"3624738v1.0:4291742v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3624738","version":"1","preferredName":"Accelerated Phase of Disease Finding Present","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression._Clinical, laboratory or molecular evidence, or absence of evidence of disease._Being or existing in a specified place or at the specified time.","longName":"4285041v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4285041","version":"1","preferredName":"Accelerated Phase of Disease Finding","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C36155:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F84480CD-6711-7BD7-E040-BB89AD436CEA","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD864119-728C-20DF-E040-BB89AD433C55","latestVersionIndicator":"Yes","beginDate":"2012-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-02","modifiedBy":"KUMMEROA","dateModified":"2020-12-16","changeDescription":". 2020-12-16 ak OK to release per WZ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4291742","version":"1","preferredName":"Accelerated Phase of Disease Finding Type","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression._Clinical, laboratory or molecular evidence, or absence of evidence of disease._Something distinguishable as an identifiable class based on common qualities.","longName":"4291742v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"4291759","version":"1","preferredName":"Anemia","longName":"4291759","preferredDefinition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6419-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-6431-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Abnormal liver function","valueDescription":"Liver Dysfunction","ValueMeaning":{"publicId":"4291760","version":"1","preferredName":"Liver Dysfunction","longName":"4291760","preferredDefinition":"A finding that indicates abnormal liver function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Dysfunction","conceptCode":"C50634","definition":"A finding that indicates abnormal liver function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-643D-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-6456-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Abnormal CSF","valueDescription":"Abnormal Cerebrospinal Fluid","ValueMeaning":{"publicId":"4291761","version":"1","preferredName":"Abnormal Cerebrospinal Fluid","longName":"4291761","preferredDefinition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: The fluid that flows in and around the hollow spaces of the brain and spinal cord, and between two of the meninges (the thin layers of tissue that cover and protect the brain and spinal cord). CSF is made by tissue called the choroid plexus in the ventricles (hollow spaces) in the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cerebrospinal Fluid","conceptCode":"C12692","definition":"The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6463-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-647C-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Cytomegalovirus","valueDescription":"Infectious Disorder Cytomegalovirus","ValueMeaning":{"publicId":"4291765","version":"1","preferredName":"Infectious Disorder Cytomegalovirus","longName":"4291765","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.: A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytomegalovirus","conceptCode":"C14196","definition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-648B-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-64A4-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Dense bodies (delta granules) on electron micrograph (EM) of platelets","valueDescription":"Electron Microscopy Platelet Dense Granule","ValueMeaning":{"publicId":"4291744","version":"1","preferredName":"Electron Microscopy Platelet Dense Granule","longName":"4291744","preferredDefinition":"Any form of microscopy in which the interactions of electrons with the specimens are used to provide information about the final structure of that specimen.: An irregular, disc-shaped element in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes.: Having high relative density or specific gravity; permitting little if any light to pass through.: Any small grainlike particle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Electron Microscopy","conceptCode":"C16854","definition":"Any form of microscopy in which the interactions of electrons with the specimens are used to provide information about the final structure of that specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Platelet","conceptCode":"C12520","definition":"An irregular, disc-shaped element in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dense","conceptCode":"C61562","definition":"Having high relative density or specific gravity; permitting little if any light to pass through.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Granule","conceptCode":"C61363","definition":"Any small grainlike particle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-61F6-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-620F-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Other feature associated with accelerated phase","valueDescription":"Accelerated Phase of Disease Associated Other Feature","ValueMeaning":{"publicId":"4291747","version":"1","preferredName":"Accelerated Phase of Disease Associated Other Feature","longName":"4291747","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.: Joined in some kind of relationship.: Different than the one(s) previously specified or mentioned.: A prominent or identifiable aspect, region, or site of interest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-626B-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-6284-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"CSF lymphocytosis","valueDescription":"Cerebrospinal Fluid Lymphocytosis","ValueMeaning":{"publicId":"4291745","version":"1","preferredName":"Cerebrospinal Fluid Lymphocytosis","longName":"4291745","preferredDefinition":"The fluid that flows in and around the hollow spaces of the brain and spinal cord, and between two of the meninges (the thin layers of tissue that cover and protect the brain and spinal cord). CSF is made by tissue called the choroid plexus in the ventricles (hollow spaces) in the brain.: A laboratory test result indicating an abnormal increase in the number of lymphocytes in the peripheral blood, effusions, or bone marrow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebrospinal Fluid","conceptCode":"C12692","definition":"The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphocytosis","conceptCode":"C34791","definition":"A finding indicating the presence of a non-neoplastic or neoplastic proliferation of lymphocytes in the peripheral blood, effusions, or bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-621C-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-6235-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Hyperferritinemia","valueDescription":"Blood Elevated Ferritin","ValueMeaning":{"publicId":"4291746","version":"1","preferredName":"Blood Elevated Ferritin","longName":"4291746","preferredDefinition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: Raised or increased above normal levels or limits.: An iron protein complex, containing up to 23% iron, formed by the union of ferric iron with apoferritin; it is found in the intestinal mucosa, spleen, bone marrow, reticulocytes, and liver, and regulates iron storage and transport from the intestinal lumen to plasma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood","conceptCode":"C12434","definition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ferritin","conceptCode":"C16577","definition":"An iron protein complex, containing up to 23% iron, formed by the union of ferric iron with apoferritin; it is found in the intestinal mucosa, spleen, bone marrow, reticulocytes, and liver, and regulates iron storage and transport from the intestinal lumen to plasma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6243-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-625C-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Other viral infection associated with accelerated phase","valueDescription":"Accelerated Phase of Disease Associated Other Viral Infection","ValueMeaning":{"publicId":"4291748","version":"1","preferredName":"Accelerated Phase of Disease Associated Other Viral Infection","longName":"4291748","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.: Joined in some kind of relationship.: Different than the one(s) previously specified or mentioned.: Any disease caused by a virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Viral Infection","conceptCode":"C3439","definition":"Any disease caused by a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6293-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-62AC-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Elevated triglycerides","valueDescription":"Hypertriglyceridemia","ValueMeaning":{"publicId":"4291749","version":"1","preferredName":"Hypertriglyceridemia","longName":"4291749","preferredDefinition":"A laboratory test result indicating elevated triglyceride concentration in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertriglyceridemia","conceptCode":"C37971","definition":"A laboratory test result indicating elevated triglyceride concentration in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-62B6-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-62CE-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Epstein-Barr virus","valueDescription":"Infectious Disorder Epstein-Barr Virus","ValueMeaning":{"publicId":"4291750","version":"1","preferredName":"Infectious Disorder Epstein-Barr Virus","longName":"4291750","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.: A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-62DB-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-62F4-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Hypofibrinogenemia","valueDescription":"Hypofibrinogenemia","ValueMeaning":{"publicId":"3285367","version":"1","preferredName":"Hypofibrinogenemia","longName":"3285367","preferredDefinition":"A blood coagulation disorder characterized by low levels of fibrinogen in the blood, resulting in bleeding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypofibrinogenemia","conceptCode":"C98131","definition":"A blood coagulation disorder characterized by low levels of fibrinogen in the blood, resulting in bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADDDD4D5-09FD-A1C9-E040-BB89AD43373A","latestVersionIndicator":"Yes","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-630B-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Lymphadenopathy","valueDescription":"Lymphadenopathy","ValueMeaning":{"publicId":"4291752","version":"1","preferredName":"Lymphadenopathy","longName":"4291752","preferredDefinition":"An enlarged lymph node. Causes include viral and bacterial infections and cancers that affect the lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphadenopathy","conceptCode":"C50764","definition":"An enlarged lymph node. Causes include viral and bacterial infections and cancers that affect the lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6315-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-632D-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Thrombocytopenia","valueDescription":"Thrombocytopenia","ValueMeaning":{"publicId":"2946035","version":"1","preferredName":"Thrombocytopenia","longName":"2946035","preferredDefinition":"A condition in which there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D443-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-6337-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Hyponatremia","valueDescription":"Hyponatremia","ValueMeaning":{"publicId":"4291753","version":"1","preferredName":"Hyponatremia","longName":"4291753","preferredDefinition":"Lower than normal levels of sodium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyponatremia","conceptCode":"C37976","definition":"Lower than normal levels of sodium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6341-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-635A-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Fevers","valueDescription":"Fever","ValueMeaning":{"publicId":"4291754","version":"1","preferredName":"Fever","longName":"4291754","preferredDefinition":"Elevation of body temperature above normal due to inflammatory or immune responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6364-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-637C-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Splenomegaly","valueDescription":"Splenomegaly","ValueMeaning":{"publicId":"4291755","version":"1","preferredName":"Splenomegaly","longName":"4291755","preferredDefinition":"Abnormal enlargement of the spleen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Splenomegaly","conceptCode":"C3384","definition":"Abnormal enlargement of the spleen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6386-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-639E-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Neurologic dysfunction","valueDescription":"Neurological Deficit or Dysfunction","ValueMeaning":{"publicId":"4291756","version":"1","preferredName":"Neurological Deficit or Dysfunction","longName":"4291756","preferredDefinition":"A finding of pathologic function within the central or peripheral nervous system, secondary to developmental abnormalities, infections, neurologic damage, or tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurological Deficit or Dysfunction","conceptCode":"C50672","definition":"A finding of pathologic function within the central or peripheral nervous system, secondary to developmental abnormalities, infections, neurologic damage, or tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-63A8-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-63C1-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Hemophagocytosis","valueDescription":"hemophagocytosis","ValueMeaning":{"publicId":"2579881","version":"1","preferredName":"hemophagocytosis","longName":"2579881","preferredDefinition":"The term hemophagocytosis describes the pathologic finding of activated macrophages, engulfing erythrocytes, leukocytes, platelets, and their precursor cells. (from Medscape: Hemophagocytic Syndromes and Infection)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophagocytosis","conceptCode":"C35985","definition":"The term hemophagocytosis describes the pathologic finding of activated macrophages, engulfing erythrocytes, leukocytes, platelets, and their precursor cells. (from Medscape: Hemophagocytic Syndromes and Infection)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0516-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-63CB-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Neutropenia","valueDescription":"Neutropenia","ValueMeaning":{"publicId":"4291757","version":"1","preferredName":"Neutropenia","longName":"4291757","preferredDefinition":"A decrease in the number of neutrophils in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutropenia","conceptCode":"C80520","definition":"A decrease in the number of neutrophils in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-63D5-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-63ED-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"},{"value":"Hepatomegaly","valueDescription":"Hepatomegaly","ValueMeaning":{"publicId":"4291758","version":"1","preferredName":"Hepatomegaly","longName":"4291758","preferredDefinition":"Abnormal enlargement of the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatomegaly","conceptCode":"C3100","definition":"Abnormal enlargement of the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-63F7-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8ABEA26-640F-ED7C-E040-BB89AD4312B2","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4291767","version":"1","preferredName":"Accelerated Phase of Disease Finding Type","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.:Something distinguishable as an identifiable class based on common qualities.","longName":"C36155:C3367:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8AD0F3F-D55E-8EB0-E040-BB89AD4346D2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA","dateModified":"2014-05-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-61DB-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"KUMMEROA","dateModified":"2021-01-07","changeDescription":". 2021-1-7 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What type of accelerated phas","type":"Preferred Question Text","description":"What type of accelerated phase findings are present?","url":null,"context":"NHLBI"},{"name":"What accelerated phase features are present?","type":"Alternate Question Text","description":"What accelerated phase features are present?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ACD2B8-EB96-B79F-E040-BB89AD4339FE","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"KUMMEROA","dateModified":"2021-01-07","changeDescription":". 2021-1-7 ak OK to release per WZ. System generated def displayed as alt def. AK 11/17/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}